Contract development and manufacturing organisations (CDMOs) play an essential role in today’s life science industry. As biotech and pharmaceutical companies focus on research and innovation, many rely on specialised partners to support development, testing, and manufacturing. Through its network and collaborative environment, Medeon Science Park helps connect companies with these important capabilities.
Medeon Science Park is part of Medicon Valley, one of Europe’s strongest life science clusters spanning Eastern Denmark and Southern Sweden, with a particularly strong position within CDMO, biopharma and advanced manufacturing.
The ecosystem includes internationally recognized companies such as Novo Nordisk, Ferring Pharmaceuticals, PolyPeptide Group, AGC Biologics and FUJIFILM Diosynth Biotechnologies, alongside a large number of innovative startups and scaleups.
Malmö plays an important role in the Medicon Valley ecosystem, particularly within medtech, manufacturing-oriented life science and applied innovation, while offering direct access to the broader CDMO and production network across the region.
Here, you can explore profiles of CDMOs in Malmö, each contributing important expertise to the life science ecosystem. Together, they represent a strong network of experts that support life science companies at different stages of development, helping transform scientific ideas into viable products and bringing innovations closer to patients and the market.
Located in Malmö, Medeon Science Park serves as a hub where companies, experts, and investors converge to advance innovation in the life science sector. Its dynamic environment integrates research, commercialisation, and collaboration, strengthened by close ties to Lund University, Malmö University, and Skåne University Hospital. Participation within this network promotes collaboration, growth, and shared success across the community.
Through our Life Science Network, which includes our featured CDMO partners, we collaborate with locally embedded experts who provide valuable insights, reliable delivery, and high-quality standards that meet regulatory and industry requirements. From developing new therapies to scaling production, the network supports projects at every stage.